Filing Details

Accession Number:
0001209191-23-028866
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-05-11 20:54:15
Reporting Period:
2023-05-09
Accepted Time:
2023-05-11 20:54:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1962918 Acelyrin Inc. SLRN Pharmaceutical Preparations (2834) 852406735
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1973848 Paul Peloso C/O Acelyrin, Inc.
4149 Liberty Canyon Rd.
Agoura Hills CA 91301
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-05-09 6,000 $18.00 6,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common Stock Employee Stock Option (right to buy) Disposition 2023-05-09 173,681 $0.00 173,681 $0.77
Common Stock Employee Stock Option (right to buy) Acquisiton 2023-05-09 173,681 $0.00 173,681 $0.77
Class A Common Stock Employee Stock Option (right to buy) Disposition 2023-05-09 156,500 $0.00 156,500 $4.04
Common Stock Employee Stock Option (right to buy) Acquisiton 2023-05-09 156,500 $0.00 156,500 $4.04
Class A Common Stock Employee Stock Option (right to buy) Disposition 2023-05-09 187,988 $0.00 187,988 $5.88
Common Stock Employee Stock Option (right to buy) Acquisiton 2023-05-09 187,988 $0.00 187,988 $5.88
Class A Common Stock Employee Stock Option (right to buy) Disposition 2023-05-09 154,957 $0.00 154,957 $18.00
Common Stock Employee Stock Option (right to buy) Acquisiton 2023-05-09 154,957 $0.00 154,957 $18.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2031-07-25 No 4 J Direct
173,681 2031-07-25 No 4 J Direct
0 2032-01-19 No 4 J Direct
156,500 2032-01-19 No 4 J Direct
0 2032-11-20 No 4 J Direct
187,988 2032-11-20 No 4 J Direct
0 2033-05-03 No 4 J Direct
154,957 2033-05-03 No 4 J Direct
Footnotes
  1. Reflects shares purchased through a directed share program in the Issuer's initial public offering of Common Stock (the "IPO").
  2. Each share of Class A Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the IPO.
  3. 1/4 of the shares subject to the option vested on May 16, 2022 and 1/48 of the shares subject to the option vests in equal monthly installments thereafter, subject to the Reporting Person's continued service.
  4. 1/4 of the shares subject to the option vested on January 20, 2023, and 1/48 of the shares subject to the option vest in equal monthly installments thereafter, subject to the Reporting Person's continued service.
  5. 1/4 of the shares subject to the option vest on November 17, 2023, and 1/48 of the shares subject to the option vests in equal monthly installments thereafter, subject to the Reporting Person's continued service.
  6. 1/4 of the shares subject to the option vest on May 4, 2024, and 1/48 of the shares subject to the option vest in equal monthly installments thereafter, subject to the Reporting Person's continued service.